Your Good Health: New pacemakers are made to be safe to use in an MRI - Times Colonist

Nfld. & LabradorA joint government and health authority announcement on a new magnetic resonance imaging machine (MRI) coming to Grand Falls-Windsor, planned to be in service next year, has spurred concern and questions from technologists in the province. The health-care workers would like to be provided a human resources plan before further celebratory events, an advocate says. Wait times for urgent MRIs more than doubled last fiscal year, states NLHSAshley Fitzpatrick · CBC News · Posted: Oct 07, 2026 4:30 AM EDT | Last Updated: October 7Listen to this articleEstimated 4 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. An MRI machine. (CBC)The announcement of a magnetic resonance imaging machine (MRI) coming to Grand Falls-Windsor came as announcements of multi-million dollar medical equipment always do in Newfoundland and Labrador, according to an advocate for MRI technologists in Atlantic Canada.

The Canadian Centre for Policy Alternatives joined Ontario Council of Hospital Unions of CUPE in pushing back against the privatization of health care during a media event in Sudbury Pushing back against the province’s privatization of health care, the Canadian Centre for Policy Alternatives has joined CUPE in a media tour of the province.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.